{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:10:50Z","timestamp":1793833850859,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NSTC","award":["114-2314-B-037-115"],"award-info":[{"award-number":["114-2314-B-037-115"]}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["113-3R45"],"award-info":[{"award-number":["113-3R45"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["P30-EY008098"],"award-info":[{"award-number":["P30-EY008098"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["unrestricted research grant"],"award-info":[{"award-number":["unrestricted research grant"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35409-5","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:24:59Z","timestamp":1768037099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quercetin attenuates high glucose-induced VEGFA expression in ARPE-19 cells by inhibiting ROS generation, p38 MAPK phosphorylation, and NF-\u03baB activation"],"prefix":"10.1038","volume":"16","author":[{"given":"Pei-Kang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chang","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Che","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"35409_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41591-023-02702-z","volume":"30","author":"L Dai","year":"2024","unstructured":"Dai, L. et al. A deep learning system for predicting time to progression of diabetic retinopathy. Nat. Med. 30, 584\u2013594 (2024).","journal-title":"Nat. Med."},{"key":"35409_CR2","doi-asserted-by":"crossref","unstructured":"Khazeei Tabari, M. A. et al. Nature against diabetic retinopathy: a review on antiangiogenic, antioxidant, and anti-inflammatory phytochemicals. Evid. Based Complement. Altern. Med. 2022, 4708527 (2022).","DOI":"10.1155\/2022\/4708527"},{"key":"35409_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.survophthal.2021.03.001","volume":"66","author":"Y Tan","year":"2021","unstructured":"Tan, Y. et al. Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: a review. Surv. Ophthalmol. 66, 926\u2013932 (2021).","journal-title":"Surv. Ophthalmol."},{"key":"35409_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","volume":"54","author":"A Arrigo","year":"2022","unstructured":"Arrigo, A., Aragona, E. & Bandello, F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy. Ann. Med. 54, 1089\u20131111 (2022).","journal-title":"Ann. Med."},{"key":"35409_CR5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/ceo.13579","volume":"47","author":"B Bahrami","year":"2019","unstructured":"Bahrami, B. et al. Effects of VEGF inhibitors on human retinal pigment epithelium under high glucose and hypoxia. Clin. Exp. Ophthalmol. 47, 1074\u20131081 (2019).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"35409_CR6","doi-asserted-by":"publisher","first-page":"174014","DOI":"10.1016\/j.ejphar.2021.174014","volume":"899","author":"RE Anitha","year":"2021","unstructured":"Anitha, R. E., Janani, R., Peethambaran, D. & Baskaran, V. Lactucaxanthin protects retinal pigment epithelium from hyperglycemia-regulated hypoxia\/ER stress\/VEGF pathway mediated angiogenesis in ARPE-19 cell and rat model. Eur. J. Pharmacol. 899, 174014 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"35409_CR7","unstructured":"Maugeri, G. et al. (2021)."},{"key":"35409_CR8","doi-asserted-by":"crossref","unstructured":"Hodgson, R. et al. A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy. Health Technol. Assess. (Winchester England), 1 (2025).","DOI":"10.3310\/NHYK3694"},{"key":"35409_CR9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/09205063.2024.2406628","volume":"36","author":"J Li","year":"2025","unstructured":"Li, J. et al. ROS-responsive nanoparticles with antioxidative effect for the treatment of diabetic retinopathy. J. Biomater. Sci. Polym. Ed. 36, 440\u2013461 (2025).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"35409_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/jcmm.12748","volume":"20","author":"E Turillazzi","year":"2016","unstructured":"Turillazzi, E. et al. Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF\u2010kB. J. Cell. Mol. Med. 20, 601\u2013612 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"35409_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s42003-023-05664-7","volume":"7","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z. et al. Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Commun. Biology. 7, 18 (2024).","journal-title":"Commun. Biology"},{"key":"35409_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal. Transduct. Target. Therapy. 8, 152 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"35409_CR13","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells. (2012).","DOI":"10.1371\/journal.pone.0047600"},{"key":"35409_CR14","doi-asserted-by":"publisher","unstructured":"Gomez-Jimenez, V., Matas, B. S. L., Ortega, A. L. & R. & Modulation of oxidative stress in diabetic retinopathy: therapeutic role of natural polyphenols. Antioxidants (Basel). 14. https:\/\/doi.org\/10.3390\/antiox14070875 (2025).","DOI":"10.3390\/antiox14070875"},{"key":"35409_CR15","doi-asserted-by":"publisher","first-page":"1517964","DOI":"10.3389\/fphar.2025.1517964","volume":"16","author":"T Gong","year":"2025","unstructured":"Gong, T. et al. Study on the mechanism of plant metabolites to intervene oxidative stress in diabetic retinopathy. Front. Pharmacol. 16, 1517964. https:\/\/doi.org\/10.3389\/fphar.2025.1517964 (2025).","journal-title":"Front. Pharmacol."},{"key":"35409_CR16","doi-asserted-by":"publisher","unstructured":"Zhao, Y., Chen, Y. & Yan, N. The role of natural products in diabetic retinopathy. Biomedicines. 12 https:\/\/doi.org\/10.3390\/biomedicines12061138 (2024).","DOI":"10.3390\/biomedicines12061138"},{"key":"35409_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/biom9050174","volume":"9","author":"D Kashyap","year":"2019","unstructured":"Kashyap, D. et al. Fisetin and quercetin: promising flavonoids with chemopreventive potential. Biomolecules 9, 174 (2019).","journal-title":"Biomolecules"},{"key":"35409_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3390\/molecules24071297","volume":"24","author":"ME Rubio-Ruiz","year":"2019","unstructured":"Rubio-Ruiz, M. E. et al. Resveratrol and quercetin administration improves antioxidant DEFENSES and reduces fatty liver in metabolic syndrome rats. Molecules 24, 1297 (2019).","journal-title":"Molecules"},{"key":"35409_CR19","doi-asserted-by":"publisher","first-page":"124425","DOI":"10.1016\/j.jenvman.2025.124425","volume":"376","author":"K Li","year":"2025","unstructured":"Li, K. et al. New insights into quercetin\u2019s attenuation of TBBPA-induced injury to MCEC cells: involvement of the p38\/NF-\u03baB pathway and pyroptosis. J. Environ. Manage. 376, 124425 (2025).","journal-title":"J. Environ. Manage."},{"key":"35409_CR20","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1167\/iovs.02-0655","volume":"44","author":"WJ Lukiw","year":"2003","unstructured":"Lukiw, W. J. et al. Coordinate activation of HIF-1 and NF-\u03baB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Investig. Ophthalmol. Vis. Sci. 44, 4163\u20134170 (2003).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"35409_CR21","doi-asserted-by":"publisher","first-page":"111371","DOI":"10.1016\/j.biopha.2021.111371","volume":"137","author":"L Zhao","year":"2021","unstructured":"Zhao, L., Wang, H. & Du, X. The therapeutic use of quercetin in ophthalmology: recent applications. Biomed. Pharmacother. 137, 111371 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"35409_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/scipharm89020023","volume":"89","author":"T Uttarawichien","year":"2021","unstructured":"Uttarawichien, T. et al. Quercetin inhibits colorectal cancer cells induced-angiogenesis in both colorectal cancer cell and endothelial cell through downregulation of VEGF-A\/VEGFR2. Sci. Pharm. 89, 23 (2021).","journal-title":"Sci. Pharm."},{"key":"35409_CR23","doi-asserted-by":"publisher","first-page":"2442369","DOI":"10.1080\/09540105.2024.2442369","volume":"35","author":"X Zeng","year":"2024","unstructured":"Zeng, X. et al. Effects of micronutrients and macronutrients on risk of allergic disease in the European population: a Mendelian randomization study. Food Agricultural Immunol. 35, 2442369 (2024).","journal-title":"Food Agricultural Immunol."},{"key":"35409_CR24","doi-asserted-by":"publisher","first-page":"2529306","DOI":"10.1080\/09540105.2025.2529306","volume":"36","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Genetic evidence for a protective role of Omega-3 fatty acids in nummular dermatitis. Food Agricultural Immunol. 36, 2529306 (2025).","journal-title":"Food Agricultural Immunol."},{"key":"35409_CR25","doi-asserted-by":"publisher","first-page":"104588","DOI":"10.3748\/wjg.v31.i14.104588","volume":"31","author":"KJ Li","year":"2025","unstructured":"Li, K. J. et al. Prognostic scoring system using inflammation- and nutrition-related biomarkers to predict prognosis in stage I-III colorectal cancer patients. World J. Gastroenterol. 31, 104588. https:\/\/doi.org\/10.3748\/wjg.v31.i14.104588 (2025).","journal-title":"World J. Gastroenterol."},{"key":"35409_CR26","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1167\/iovs.06-0738","volume":"48","author":"W Ma","year":"2007","unstructured":"Ma, W. et al. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Investig. Ophthalmol. Vis. Sci. 48, 1355\u20131361 (2007).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"35409_CR27","doi-asserted-by":"publisher","first-page":"963615","DOI":"10.3389\/fcell.2022.963615","volume":"10","author":"L Wei","year":"2022","unstructured":"Wei, L. et al. The pathophysiological mechanisms underlying diabetic retinopathy. Front. Cell. Dev. Biology. 10, 963615 (2022).","journal-title":"Front. Cell. Dev. Biology"},{"key":"35409_CR28","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","volume":"103","author":"MJ Tolentino","year":"1996","unstructured":"Tolentino, M. J. et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103, 1820\u20131828 (1996).","journal-title":"Ophthalmology"},{"key":"35409_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","volume":"37","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3, R., Sundstrom, J. M. & Antonetti, D. A. Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care. 37, 893\u2013899 (2014).","journal-title":"Diabetes Care"},{"key":"35409_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ophtha.2020.07.062","volume":"128","author":"MH Maloney","year":"2021","unstructured":"Maloney, M. H. et al. Risk of systemic adverse events after intravitreal bevacizumab, ranibizumab, and aflibercept in routine clinical practice. Ophthalmology 128, 417\u2013424 (2021).","journal-title":"Ophthalmology"},{"key":"35409_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/antiox9040347","volume":"9","author":"B Dom\u00e8nech","year":"2020","unstructured":"Dom\u00e8nech, B., Marfany, G. & E. & The relevance of oxidative stress in the pathogenesis and therapy of retinal dystrophies. Antioxidants 9, 347 (2020).","journal-title":"Antioxidants"},{"key":"35409_CR32","doi-asserted-by":"publisher","first-page":"e042484","DOI":"10.1136\/bmjopen-2020-042484","volume":"10","author":"HL Jeon","year":"2020","unstructured":"Jeon, H. L. et al. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis. BMJ open. 10, e042484 (2020).","journal-title":"BMJ open."},{"key":"35409_CR33","doi-asserted-by":"crossref","unstructured":"Spooner, K. L., Guinan, G., Koller, S., Hong, T. & Chang, A. A. Burden of treatment among patients undergoing intravitreal injections for diabetic macular oedema in Australia. Diabetes Metabol. Syndrome Obes. Targets Ther. 1913\u20131921 (2019).","DOI":"10.2147\/DMSO.S214098"},{"key":"35409_CR34","doi-asserted-by":"publisher","first-page":"e56741","DOI":"10.2196\/56741","volume":"10","author":"K Choi","year":"2024","unstructured":"Choi, K. et al. Patient-centered economic burden of diabetic macular edema: retrospective cohort study. JMIR Public. Health Surveillance. 10, e56741 (2024).","journal-title":"JMIR Public. Health Surveillance"},{"key":"35409_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ssci.2015.06.002","volume":"79","author":"RJ Mitchell","year":"2015","unstructured":"Mitchell, R. J., Williamson, A. & Molesworth, B. Use of a human factors classification framework to identify causal factors for medication and medical device-related adverse clinical incidents. Saf. Sci. 79, 163\u2013174 (2015).","journal-title":"Saf. Sci."},{"key":"35409_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1507\/endocrj.EJ24-0122","volume":"71","author":"W Yu","year":"2024","unstructured":"Yu, W. & Jiang, H. Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway. Endocr. J. 71, 1045\u20131053 (2024).","journal-title":"Endocr. J."},{"key":"35409_CR37","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.3390\/molecules190812150","volume":"19","author":"HS Lee","year":"2014","unstructured":"Lee, H. S., Jun, J. H., Jung, E. H., Koo, B. A. & Kim, Y. S. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Molecules 19, 12150\u201312172 (2014).","journal-title":"Molecules"},{"key":"35409_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cbi.2014.10.007","volume":"234","author":"KC Chang","year":"2015","unstructured":"Chang, K. C., Snow, A., LaBarbera, D. V. & Petrash, J. M. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells. Chemico-Biol. Interact. 234, 254\u2013260 (2015).","journal-title":"Chemico-Biol. Interact."},{"key":"35409_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/jcp.22080","volume":"223","author":"L Wang","year":"2010","unstructured":"Wang, L. et al. Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase\u2010dependent signaling pathways. J. Cell. Physiol. 223, 713\u2013726 (2010).","journal-title":"J. Cell. Physiol."},{"key":"35409_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biom15010151","volume":"15","author":"HOA Alharbi","year":"2025","unstructured":"Alharbi, H. O. A., Alshebremi, M., Babiker, A. Y. & Rahmani, A. H. The role of quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative stress, inflammation, and biological activities. Biomolecules 15, 151 (2025).","journal-title":"Biomolecules"},{"key":"35409_CR41","doi-asserted-by":"crossref","unstructured":"Millar, C. L. et al. A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer\u2019s disease. EBioMedicine. 113 (2025).","DOI":"10.1016\/j.ebiom.2025.105612"},{"key":"35409_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ihj.2018.04.006","volume":"70","author":"N Chekalina","year":"2018","unstructured":"Chekalina, N. et al. Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease. Indian Heart J. 70, 593\u2013597 (2018).","journal-title":"Indian Heart J."},{"key":"35409_CR43","doi-asserted-by":"publisher","first-page":"1519459","DOI":"10.3389\/fnut.2025.1519459","volume":"12","author":"F Di Pierro","year":"2025","unstructured":"Di Pierro, F. et al. Potential pharmacological effect of Quercetin Phytosome\u2122 in the management of hyperuricemia: results from real-life clinical studies. Front. Nutr. 12, 1519459 (2025).","journal-title":"Front. Nutr."},{"key":"35409_CR44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12672-025-02811-w","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Anwar, M., Wang, X., Zhang, B. & Ma, B. Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer. Discov Oncol. 16, 977. https:\/\/doi.org\/10.1007\/s12672-025-02811-w (2025).","journal-title":"Discov Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35409-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35409-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35409-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:23:08Z","timestamp":1770286988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35409-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35409"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35409-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used the human retinal pigment epithelial cell line ARPE-19 (ATCC CRL-2302). No human participants or live vertebrate animals were involved; therefore, institutional ethics approval and informed consent were not required. ARPE-19 cells were authenticated by the supplier and routinely tested to confirm absence of mycoplasma contamination. All procedures complied with institutional biosafety guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4987"}}